APO RESEARCH · REPORT
Radiotherapy
Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy.
Product & engineering
Understand the product.
Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. The principle is to use high-energy ionizing radiation (such as X-rays, gamma rays, high-energy electrons or heavy particles) produced by Medical Electron Linear Accelerator or radioactive nuclei to control or destroy malignant cells. Radiation therapy can cure some cancers that are only present in specific parts of the body, and can also be used as adjuvant therapy to prevent the recurrence of tumors after surgery to remove the primary malignant tumor (for example, to treat early-stage breast cancer). Ionizing radiation can damage the DNA of cancer tissue, causing its cells to die. In order to leave normal tissues (such as skin or organs, through which radiation must pass to treat tumors) unaffected, the radiation beam will illuminate the cancerous tissue from several specific angles. Tumors produce a much greater absorbed dose than surrounding healthy tissue. In addition to the tumor itself, the radiation field may also include draining lymph nodes if they are clinically or radiologically associated with malignancy or are considered to be at risk for subclinical malignant spread. Either way, the cells are killed by destroying the genetic material (DNA) of malignant cells. Cancer cells whose DNA is damaged and cannot be repaired will stop dividing or die. When damaged cells die, they are broken down and eliminated by the body. Radiation therapy does not kill cancer cells immediately; the level of DNA damage that causes cancer cell death requires days or weeks of treatment.
Radiotherapy equipment is an important treatment tool in current tumor treatment, including Medical Electron Linear Accelerator, Gamma Knife, Cyberknife, TomoTherapy, proton and heavy ion equipment, etc., among which the global The most commonly used one is the Medical Electron Linear Accelerator. Medical Electron Linear Accelerator is usually used clinically to define and plan the treatment target area based on CT images, and to give the target area a certain dose of uniform irradiation. In radiotherapy, target volume delineation, measurement prescription design, and radiotherapy plan design can all directly affect the effect of radiotherapy. However, because delineation and design work rely on technicians and radiotherapy doctors, there are many uncertainties. The positioning error is one of the important factors affecting the accuracy of radiotherapy. In addition, there are many factors that cause positioning and imaging differences during the entire radiotherapy process for patients, making it difficult for the entire radiotherapy effect to fully achieve the intended goal.
Proton and heavy particle therapy are another modality. Proton therapy, also known as "proton knife", uses neutral uncharged particles (such as neutrons) or charged particles (such as protons) to enter the human body and release energy to kill tumor cells. Currently, protons and Carbon ions. The entire treatment process can provide powerful irradiation to tumor lesions while avoiding irradiation of normal tissues to maximize the curative effect. Proton radiotherapy is currently the most cutting-edge cancer treatment technology. In the world of cancer treatment, heavy ions are another word for carbon ions (C6+). It is said that the dose concentration of heavy ions is better than that of protons, and the killing effect on cancer cells is 2-3 times that of protons. This effect can reduce the number of fractions and shorten the treatment cycle. Heavy ion therapy is also expected to be effective in treating cancers that are resistant to conventional X-ray radiation therapy, such as sarcomas and adenocarcinomas, locally advanced cancers, and deep-seated cancers. Broadly speaking, a heavy ion beam includes any beam of particles heavier than electrons. In heavy ion radiation therapy in Japan, the term "heavy ion beam" refers to a beam of nuclei (heavy ions) of any atom heavier than helium (He) or with an atomic number greater than helium. In Japan, carbon ion beams have been used for heavy ion beam therapy for nearly 20 years. Therefore, "heavy ion beam" currently refers to "carbon ion beam".
The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.
What turns activity into demand
Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.
The commercial boundary
For Radiotherapy, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.
Which conditions determine usable radiotherapy performance?
Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.
Selected research
Market Structure
Global Radiotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. The principle is to use high-energy ionizing radiation (such as X-rays, gamma rays, high-energy electrons or heavy particles) produced by Medical Electron Linear Accelerator or radioactive nuclei to control or destroy malignant cells. Radiation therapy can cure some cancers that are only present in specific parts of the body, and can also be used as adjuvant therapy to prevent the recurrence of tumors after surgery to remove the primary malignant tumor (for example, to treat early-stage breast cancer). Ionizing radiation can damage the DNA of cancer tissue, causing its cells to die. In order to leave normal tissues (such as skin or organs, through which radiation must pass to treat tumors) unaffected, the radiation beam will illuminate the cancerous tissue from several specific angles. Tumors produce a much greater absorbed dose than surrounding healthy tissue. In addition to the tumor itself, the radiation field may also include draining lymph nodes if they are clinically or radiologically associated with malignancy or are considered to be at risk for subclinical malignant spread. Either way, the cells are killed by destroying the genetic material (DNA) of malignant cells. Cancer cells whose DNA is damaged and cannot be repaired will stop dividing or die. When damaged cells die, they are broken down and eliminated by the body. Radiation therapy does not kill cancer cells immediately; the level of DNA damage that causes cancer cell death requires days or weeks of treatment.
Radiotherapy equipment is an important treatment tool in current tumor treatment, including Medical Electron Linear Accelerator, Gamma Knife, Cyberknife, TomoTherapy, proton and heavy ion equipment, etc., among which the global The most commonly used one is the Medical Electron Linear Accelerator. Medical Electron Linear Accelerator is usually used clinically to define and plan the treatment target area based on CT images, and to give the target area a certain dose of uniform irradiation. In radiotherapy, target volume delineation, measurement prescription design, and radiotherapy plan design can all directly affect the effect of radiotherapy. However, because delineation and design work rely on technicians and radiotherapy doctors, there are many uncertainties. The positioning error is one of the important factors affecting the accuracy of radiotherapy. In addition, there are many factors that cause positioning and imaging differences during the entire radiotherapy process for patients, making it difficult for the entire radiotherapy effect to fully achieve the intended goal.
Proton and heavy particle therapy are another modality. Proton therapy, also known as "proton knife", uses neutral uncharged particles (such as neutrons) or charged particles (such as protons) to enter the human body and release energy to kill tumor cells. Currently, protons and Carbon ions. The entire treatment process can provide powerful irradiation to tumor lesions while avoiding irradiation of normal tissues to maximize the curative effect. Proton radiotherapy is currently the most cutting-edge cancer treatment technology. In the world of cancer treatment, heavy ions are another word for carbon ions (C6+). It is said that the dose concentration of heavy ions is better than that of protons, and the killing effect on cancer cells is 2-3 times that of protons. This effect can reduce the number of fractions and shorten the treatment cycle. Heavy ion therapy is also expected to be effective in treating cancers that are resistant to conventional X-ray radiation therapy, such as sarcomas and adenocarcinomas, locally advanced cancers, and deep-seated cancers. Broadly speaking, a heavy ion beam includes any beam of particles heavier than electrons. In heavy ion radiation therapy in Japan, the term "heavy ion beam" refers to a beam of nuclei (heavy ions) of any atom heavier than helium (He) or with an atomic number greater than helium. In Japan, carbon ion beams have been used for heavy ion beam therapy for nearly 20 years. Therefore, "heavy ion beam" currently refers to "carbon ion beam".
Read the full market overview
The global Radiotherapy market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Asia Pacific market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Radiotherapy include Varian Medical Systems (Siemens Healthineers), Elekta, Hitachi, IBA(Ion Beam Applications S.A), Accuray, Mevion Medical Systems, Shanghai United Imaging Healthcare, Shinva Medical Instrument and Toshiba, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Radiotherapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radiotherapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radiotherapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiotherapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Radiotherapy Segment by Company
Varian Medical Systems (Siemens Healthineers)
Elekta
Hitachi
IBA(Ion Beam Applications S.A)
Accuray
Mevion Medical Systems
Shanghai United Imaging Healthcare
Shinva Medical Instrument
Toshiba
Neusoft Medical Systems
Chengdu Linike Medical
Sumitomo Heavy Industries
Jiangsu Haiming Medical Equipment
SinoPower Accelerator
Radiotherapy Segment by Type
External Beam Radiotherapy
Internal Beam Radiotherapy
Radiotherapy Segment by Application
Lung Cancer
Breast Cancer
Rectal Cancer
Prostate Cancer
Stomach Cancer
Liver Cancer
Cervical Cancer
Lung Cancer
Head and Neck Cancer
Other
Radiotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiotherapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Radiotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- External Beam Radiotherapy
- Internal Beam Radiotherapy
Applications
- Lung Cancer
- Breast Cancer
- Rectal Cancer
- Prostate Cancer
- Stomach Cancer
- Liver Cancer
- Cervical Cancer
- Lung Cancer
- Head and Neck Cancer
- Other
Companies covered
- Varian Medical Systems (Siemens Healthineers)
- Elekta
- Hitachi
- IBA(Ion Beam Applications S.A)
- Accuray
- Mevion Medical Systems
- Shanghai United Imaging Healthcare
- Shinva Medical Instrument
- Toshiba
- Neusoft Medical Systems
- Chengdu Linike Medical
- Sumitomo Heavy Industries
- Jiangsu Haiming Medical Equipment
- SinoPower Accelerator
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Radiotherapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Radiotherapy Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Radiotherapy Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Radiotherapy Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Radiotherapy Market Dynamics
- 2.1 Radiotherapy Industry Trends
- 2.2 Radiotherapy Industry Drivers
- 2.3 Radiotherapy Industry Opportunities and Challenges
- 2.4 Radiotherapy Industry Restraints
3 Radiotherapy Market by Manufacturers
- 3.1 Global Radiotherapy Revenue by Manufacturers (2021-2026)
- 3.2 Global Radiotherapy Sales by Manufacturers (2021-2026)
- 3.3 Global Radiotherapy Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Radiotherapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Radiotherapy Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Radiotherapy Manufacturers, Product Type & Application
- 3.7 Global Radiotherapy Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Radiotherapy Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Radiotherapy Players Market Share by Revenue in 2025
- 3.8.3 2025 Radiotherapy Tier 1, Tier 2, and Tier 3
4 Radiotherapy Market by Type
- 4.1 Radiotherapy Type Introduction
- 4.1.1 External Beam Radiotherapy
- 4.1.2 Internal Beam Radiotherapy
- 4.2 Global Radiotherapy Sales by Type
- 4.2.1 Global Radiotherapy Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radiotherapy Sales by Type (2021-2032)
- 4.2.3 Global Radiotherapy Sales Market Share by Type (2021-2032)
- 4.3 Global Radiotherapy Revenue by Type
- 4.3.1 Global Radiotherapy Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Radiotherapy Revenue by Type (2021-2032)
- 4.3.3 Global Radiotherapy Revenue Market Share by Type (2021-2032)
5 Radiotherapy Market by Application
- 5.1 Radiotherapy Application Introduction
- 5.1.1 Lung Cancer
- 5.1.2 Breast Cancer
- 5.1.3 Rectal Cancer
- 5.1.4 Prostate Cancer
- 5.1.5 Stomach Cancer
- 5.1.6 Liver Cancer
- 5.1.7 Cervical Cancer
- 5.1.8 Lung Cancer
- 5.1.9 Head and Neck Cancer
- 5.1.10 Other
- 5.2 Global Radiotherapy Sales by Application
- 5.2.1 Global Radiotherapy Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radiotherapy Sales by Application (2021-2032)
- 5.2.3 Global Radiotherapy Sales Market Share by Application (2021-2032)
- 5.3 Global Radiotherapy Revenue by Application
- 5.3.1 Global Radiotherapy Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Radiotherapy Revenue by Application (2021-2032)
- 5.3.3 Global Radiotherapy Revenue Market Share by Application (2021-2032)
6 Global Radiotherapy Sales by Region
- 6.1 Global Radiotherapy Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Radiotherapy Sales by Region (2021-2032)
- 6.2.1 Global Radiotherapy Sales by Region (2021-2026)
- 6.2.2 Global Radiotherapy Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Radiotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Radiotherapy Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Radiotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Radiotherapy Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Radiotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Radiotherapy Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Radiotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Radiotherapy Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Radiotherapy Revenue by Region
- 7.1 Global Radiotherapy Revenue by Region
- 7.1.1 Global Radiotherapy Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Radiotherapy Revenue by Region (2021-2026)
- 7.1.3 Global Radiotherapy Revenue by Region (2027-2032)
- 7.1.4 Global Radiotherapy Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Radiotherapy Revenue (2021-2032)
- 7.2.2 North America Radiotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Radiotherapy Revenue (2021-2032)
- 7.3.2 Europe Radiotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Radiotherapy Revenue (2021-2032)
- 7.4.2 Asia-Pacific Radiotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Radiotherapy Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Radiotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Varian Medical Systems (Siemens Healthineers)
- 8.1.1 Varian Medical Systems (Siemens Healthineers) Company Information
- 8.1.2 Varian Medical Systems (Siemens Healthineers) Business Overview
- 8.1.3 Varian Medical Systems (Siemens Healthineers) Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Varian Medical Systems (Siemens Healthineers) Radiotherapy Product Portfolio
- 8.1.5 Varian Medical Systems (Siemens Healthineers) Recent Developments
- 8.2 Elekta
- 8.2.1 Elekta Company Information
- 8.2.2 Elekta Business Overview
- 8.2.3 Elekta Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Elekta Radiotherapy Product Portfolio
- 8.2.5 Elekta Recent Developments
- 8.3 Hitachi
- 8.3.1 Hitachi Company Information
- 8.3.2 Hitachi Business Overview
- 8.3.3 Hitachi Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hitachi Radiotherapy Product Portfolio
- 8.3.5 Hitachi Recent Developments
- 8.4 IBA(Ion Beam Applications S.A)
- 8.4.1 IBA(Ion Beam Applications S.A) Company Information
- 8.4.2 IBA(Ion Beam Applications S.A) Business Overview
- 8.4.3 IBA(Ion Beam Applications S.A) Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 IBA(Ion Beam Applications S.A) Radiotherapy Product Portfolio
- 8.4.5 IBA(Ion Beam Applications S.A) Recent Developments
- 8.5 Accuray
- 8.5.1 Accuray Company Information
- 8.5.2 Accuray Business Overview
- 8.5.3 Accuray Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Accuray Radiotherapy Product Portfolio
- 8.5.5 Accuray Recent Developments
- 8.6 Mevion Medical Systems
- 8.6.1 Mevion Medical Systems Company Information
- 8.6.2 Mevion Medical Systems Business Overview
- 8.6.3 Mevion Medical Systems Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mevion Medical Systems Radiotherapy Product Portfolio
- 8.6.5 Mevion Medical Systems Recent Developments
- 8.7 Shanghai United Imaging Healthcare
- 8.7.1 Shanghai United Imaging Healthcare Company Information
- 8.7.2 Shanghai United Imaging Healthcare Business Overview
- 8.7.3 Shanghai United Imaging Healthcare Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shanghai United Imaging Healthcare Radiotherapy Product Portfolio
- 8.7.5 Shanghai United Imaging Healthcare Recent Developments
- 8.8 Shinva Medical Instrument
- 8.8.1 Shinva Medical Instrument Company Information
- 8.8.2 Shinva Medical Instrument Business Overview
- 8.8.3 Shinva Medical Instrument Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Shinva Medical Instrument Radiotherapy Product Portfolio
- 8.8.5 Shinva Medical Instrument Recent Developments
- 8.9 Toshiba
- 8.9.1 Toshiba Company Information
- 8.9.2 Toshiba Business Overview
- 8.9.3 Toshiba Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Toshiba Radiotherapy Product Portfolio
- 8.9.5 Toshiba Recent Developments
- 8.10 Neusoft Medical Systems
- 8.10.1 Neusoft Medical Systems Company Information
- 8.10.2 Neusoft Medical Systems Business Overview
- 8.10.3 Neusoft Medical Systems Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Neusoft Medical Systems Radiotherapy Product Portfolio
- 8.10.5 Neusoft Medical Systems Recent Developments
- 8.11 Chengdu Linike Medical
- 8.11.1 Chengdu Linike Medical Company Information
- 8.11.2 Chengdu Linike Medical Business Overview
- 8.11.3 Chengdu Linike Medical Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Chengdu Linike Medical Radiotherapy Product Portfolio
- 8.11.5 Chengdu Linike Medical Recent Developments
- 8.12 Sumitomo Heavy Industries
- 8.12.1 Sumitomo Heavy Industries Company Information
- 8.12.2 Sumitomo Heavy Industries Business Overview
- 8.12.3 Sumitomo Heavy Industries Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Sumitomo Heavy Industries Radiotherapy Product Portfolio
- 8.12.5 Sumitomo Heavy Industries Recent Developments
- 8.13 Jiangsu Haiming Medical Equipment
- 8.13.1 Jiangsu Haiming Medical Equipment Company Information
- 8.13.2 Jiangsu Haiming Medical Equipment Business Overview
- 8.13.3 Jiangsu Haiming Medical Equipment Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Jiangsu Haiming Medical Equipment Radiotherapy Product Portfolio
- 8.13.5 Jiangsu Haiming Medical Equipment Recent Developments
- 8.14 SinoPower Accelerator
- 8.14.1 SinoPower Accelerator Company Information
- 8.14.2 SinoPower Accelerator Business Overview
- 8.14.3 SinoPower Accelerator Radiotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 SinoPower Accelerator Radiotherapy Product Portfolio
- 8.14.5 SinoPower Accelerator Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Radiotherapy Value Chain Analysis
- 9.1.1 Radiotherapy Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Radiotherapy Production Mode & Process
- 9.2 Radiotherapy Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Radiotherapy Distributors
- 9.2.3 Radiotherapy Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst